Respective prevalence of high-risk HPVgenotypes in cervical neoplasia in Senegal.

Halimatou Diop NdiayeXavier Sastre-GarauAboubacry DrameBirama DembeleNafissatou N BaOumy Diop-DiongueMadeleine MbowMba E B DiakhabyGisele Woto-GayeCoumba Toure KaneMamadou Diop

Published in: Journal of medical virology (2021)

Our analysis showed that 98.4% of the HPV-positive cases were associated with viral genotypes covered by the 9-valent HPV vaccine. However, 14.1% of cases remained HPV negative. Therefore, prophylactic vaccination using a 9-valent vaccine should dramatically reduce the incidence of HPV-associated neoplasia but the detection and treatment of CIN remain necessary for the optimal prevention of cervical cancer.

Keyphrases

high grade
risk factors
cervical cancer screening
loop mediated isothermal amplification
smoking cessation
replacement therapy
quantum dots
sensitive detection